Pharmexa A/S
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. (NCT00444782) | Pharmexa A/S | 2006-11-01 |
| GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer (NCT00358566) | Pharmexa A/S | 2006-06-01 |
Track Pharmexa A/S automatically
Every clearance here is in the API, with alerts when new ones post.